UiPath: Buying Agentic AI At A 40% Discount
Despite PATH's 30% year-to-date decline, the stock remains attractive as the correction was primarily driven by broader market conditions. Currently, PATH shares trade at a significant 40% discount to peers based on EV/Sales and EV/EBITDA multiples. The transition to agent-based AI is already underway, contributing $200 million in sales growth from new products.
UiPath: With Meaningful ARR Growth, This Company Has True AI Tailwinds
UiPath remains fundamentally strong despite a ~30% YTD share price decline and broader SaaS sector pessimism. PATH continues to deliver double-digit revenue growth, expanding ARR, and robust net revenue retention, signaling resilience against AI disruption fears. The market undervalues PATH, pricing it as a disruption candidate, while its proven automation platform and industry recognition reinforce its competitive moat.
Investors Heavily Search UiPath, Inc. (PATH): Here is What You Need to Know
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why UiPath (PATH) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
UiPath's Debt-Free Balance Sheet Fuels Strategic Flexibility
PATH's debt-free balance sheet and $1.47B cash reserve give it unique flexibility to invest boldly in automation growth.
Why UiPath (PATH) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
UiPath, Inc. (PATH) is Attracting Investor Attention: Here is What You Should Know
UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is PATH Stock a Hold After Q4 Beat, Buybacks, and Margin Gains?
UiPath closes FY26 with a Q4 beat, 86% gross margin and a $1B buyback completed, but retention trends and automation spending keep the stock in a hold debate.
UiPath and Unified Automation: What's Driving ARR Growth
PATH pushes a unified automation platform as enterprises consolidate tools, supporting ARR growth, stronger pilots and expansion among larger customers.
PATH Delivers Strong Quarter to Close its Fiscal Year: Is PATH a Buy?
UiPath closes fiscal year with 14% Q4 revenue growth, $1.853B ARR, and its first full-year GAAP profit as enterprises accelerate adoption of AI-driven automation.
Stock Market Today, March 12: UiPath Shares Drop After Slower Growth Outlook Offsets First Full-Year Profit
Expand NYSE: PATH UiPath Today's Change (-7.88%) $-0.97 Current Price $11.40 Key Data Points Market Cap $6.6B Day's Range $10.70 - $11.97 52wk Range $9.38 - $19.84 Volume 5.7M Avg Vol 32M Gross Margin 83.16% UiPath (PATH 7.88%), an AI automation software provider, closed Thursday at $11.37, down 8.16%. The stock moved lower after earnings, as investors are watching how slower projected growth and price-target cuts balance against UiPath's first full-year profitability and AI automation momentum.
UiPath Fell on Good News—That Could Be the Opportunity
UiPath NYSE: PATH is on the path to a full market reversal because its March price pullback is an irrational response to good news. The company's Q4 fiscal year 2026 (FY2026) results topped expectations, with 13.4% revenue growth and net income more than doubling, yet shares pulled back.
